The US FDA announced two De Novo marketing authorisations for novel medical devices this week: A continuous glucose monitor ...

AI has kickstarted a new wave of innovation in biopharma R&D, reshaping how organisations approach some of the most complex ...

Public demand for prevention is surging, with 33.6 million people now using the NHS App, yet, NHS leaders say the digital ...

Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care, ...

A year after officially launching its AI agency offering, EVERSANA is expanding the platform’s capabilities and announcing a ...

As clinical trials become more complex, sponsors face growing pressure to reach more representative patient populations while ...

Johnson & Johnson has announced that the US Food and Drug Administration (FDA) has approved Imaavy (nipocalimab-aahu) for the ...

The European Commission has granted marketing authorisation to Gilead for Trodelvy (sacituzumab govitecan-hziy) in ...

CHB is a major public health challenge and a leading cause of liver cancer globally. Chronic hepatitis B occurs when the ...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity ...

Japanese pharma group Otsuka has signed an agreement to acquire Canada's Mindset Pharma, a specialist in psychedelic medicines for neuropsychiatric disorders. The all-cash deal – worth around C$80 ...

Eli Lilly has announced that orforglipron (Foundayo), its oral glucagon-like peptide-1 (GLP-1) receptor agonist, is now ...